{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:45:44Z","timestamp":1778669144100,"version":"3.51.4"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2230.2009.03207.x","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T15:13:11Z","timestamp":1241536391000},"page":"793-799","source":"Crossref","is-referenced-by-count":33,"title":["Perilesional treatment of metastatic melanoma with interferon-\u03b2"],"prefix":"10.1093","volume":"34","author":[{"given":"T.","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Haga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma. analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ctrv.2007.04.003","article-title":"Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review","volume":"33","author":"Petrella","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a058802","article-title":"Long term response to chemotherapy in patients with visceral metastatic melanoma","volume":"5","author":"Coates","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0025-7125(16)31889-2","article-title":"Intralesional immunotherapy of melanoma with BCG","volume":"60","author":"Rosenberg","year":"1976","journal-title":"Med Clin North Am"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB5","first-page":"335","article-title":"Preliminary experience of intralesional immunotherapy in cutaneous metastatic melanoma","volume":"49","author":"Ridolfi","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.1983.1.2.126","article-title":"A multifactorial analysis of melanoma: IV-prognostic factors in 200 melanoma patients with distant metastases (stage III)","volume":"1","author":"Balch","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00008390-200312000-00011","article-title":"Treatment of locoregional metastases of malignant melanomas with radiotherapy and intralesional \u03b2-interferon injection","volume":"13","author":"Paul","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB8","first-page":"278","article-title":"Absence of IFNA and IFNB gene from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferon","volume":"50","author":"Miyakoshi","year":"1990","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB9","first-page":"1684","article-title":"Chromosome 9 deletion mapping reveals interferon \u03b2 and interferon \u03b2-1 gene deletion in human glial tumors","volume":"51","author":"James","year":"1991","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1349-7006.2004.tb02194.x","article-title":"Interferon-beta gene therapy for cancer: basic research to clinical application","volume":"95","author":"Yoshida","year":"2004","journal-title":"Cancer Sci"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00008390-200108000-00003","article-title":"Growth inhibition of human malignant melanoma transfected with the human interferon-\u03b2 gene by means of cationic liposome","volume":"11","author":"Kageshita","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/MCB.3.5.780","article-title":"Growth regulation of melanoma cells by interferon and (2\u2032-5\u2032) oligoadenylate synthetase","volume":"3","author":"Creasey","year":"1983","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/10799900260442511","article-title":"Direct evidence that IFN-\u03b2 functions as a tumor-suppressor protein","volume":"22","author":"Kaynor","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guideline to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0167-5699(96)10027-X","article-title":"The neglected role of type I interferon in the T cell response: implication for its clinical use","volume":"17","author":"Belardelli","year":"1996","journal-title":"Immunol Today"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1610-0387.2006.06054.x","article-title":"Intralesional therapy of metastatic spreading melanoma with beta-interferon","volume":"4","author":"Rapprich","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB18","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.jid.5700777","article-title":"Imiquimod enhances the systemic attained by local cryosurgery destruction of melanoma lesions","volume":"127","author":"Redondo","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03207.x-BIB19","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1002\/eji.200636053","article-title":"Inhibitory effect of the polyinosinic-polycytidylic acid\/cationic liposome on the progression of murine B16F10 melanoma","volume":"36","author":"Fujimura","year":"2006","journal-title":"Eur J Immunol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03207.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03207.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:28:33Z","timestamp":1676384913000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/34\/7\/793\/6625222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03207.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}